JHS Svendgaard Laboratories Limited (JHS) AI Stock Analysis

• Market Cap: ₹671.99M
• Dividend Yield: N/A
• Average Volume (3M): 16.78K
• Price to Earnings (P/E): 27.3
• Beta (1Y): 0.93
• Revenue Growth: 16.77%
• EPS Growth: 34.47%
• Country: IN
• Employees: 250
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 0.09
• Shares Outstanding: 85,603,966
• 10 Day Avg. Volume: 16,348
• 30 Day Avg. Volume: 16,781
• PEG Ratio: -0.01
• Price to Book (P/B): 0.57
• Price to Sales (P/S): 1.06
• P/FCF Ratio: -6.22
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 43 Neutral
• Price Target: ₹8.00 ▼(-14.35% Downside)
• Action: Reiterated Date: 03/24/26
• Date: Action: Reiterated 03/24/26

The score is driven primarily by weak financial performance (multi-year revenue decline, ongoing losses, and negative free cash flow) and bearish technicals (price below all key moving averages with negative MACD). A strong equity base and low leverage offer some stability, but valuation (P/E 27.277 with no dividend yield provided) does not meaningfully compensate for the operating and momentum risks.

Positive Factors

Balance Sheet Strength

A very high equity ratio and minimal financial leverage provide durable financial flexibility. This balance sheet strength helps absorb operational shocks, supports working-capital financing for manufacturing, and lowers refinancing risk while management addresses operating performance.

Negative Factors

Revenue Decline

Sustained multi-year revenue erosion reduces scale and undermines fixed-cost absorption in a manufacturing business. Lower volumes pressure per-unit margins, limit pricing power with suppliers and customers, and constrain the firm's ability to leverage capacity for recovery.

JHS Svendgaard Laboratories Limited Business Overview & Revenue Model

Company Description

JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash produ...

Read more

JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash produ...

How the Company Makes Money

JHS primarily makes money by manufacturing oral care/personal care products and selling them to brand owners (including FMCG companies) under contract manufacturing and private-label agreements. Revenue is typically generated on a per-unit or per-...

Read more

JHS primarily makes money by manufacturing oral care/personal care products and selling them to brand owners (including FMCG companies) under contract manufacturing and private-label agreements. Revenue is typically generated on a per-unit or per-...

JHS Svendgaard Laboratories Limited Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	935.64M	919.97M	698.06M	840.82M	854.91M	1.00B
Gross Profit	329.55M	309.55M	203.55M	165.45M	201.68M	264.03M
EBITDA	-15.86M	-39.92M	33.78M	-163.82M	85.45M	94.57M
Net Income	-79.38M	-197.44M	-40.58M	-175.17M	-40.52M	11.98M
Balance Sheet
Total Assets	2.07B	2.01B	1.97B	2.28B	2.22B	2.28B
Cash, Cash Equivalents and Short-Term Investments	200.11M	200.16M	94.56M	386.51M	80.19M	230.38M
Total Debt	105.87M	64.58M	51.29M	155.09M	61.82M	70.11M
Total Liabilities	332.52M	284.41M	271.70M	543.87M	269.46M	299.97M
Stockholders Equity	1.74B	1.73B	1.70B	1.74B	1.86B	1.89B
Cash Flow
Free Cash Flow	-29.85M	-157.11M	-401.17M	89.43M	-158.75M	36.96M
Operating Cash Flow	-29.85M	-51.78M	-85.84M	232.86M	-91.36M	120.29M
Investing Cash Flow	92.77M	-220.18M	-217.34M	96.77M	-46.97M	-22.25M
Financing Cash Flow	38.02M	232.97M	21.74M	-9.00M	-16.72M	103.09M

JHS Svendgaard Laboratories Limited Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 9.34
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:JHS, the sentiment is Neutral. The current price of 9.34 is above the 20-day moving average (MA) of 8.02, below the 50-day MA of 9.40, and below the 200-day MA of 11.07, indicating a neutral trend. The MACD of -0.60 indicates Negative momentum. The RSI at 48.37 is Neutral, neither overbought nor oversold. The STOCH value of 48.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:JHS.

JHS Svendgaard Laboratories Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GROBTEA	70 Outperform	₹997.63M	4.09	―	0.30%	-20.04%	-104.83%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
NAGREEKEXP	52 Neutral	₹672.48M	31.72	―	―	-27.67%	-61.81%
PRITI	49 Neutral	₹491.40M	106.63	―	―	―	―
JHS	43 Neutral	₹671.99M	27.28	―	―	16.77%	34.47%

JHS Svendgaard Laboratories Limited Corporate Events